This topic contains a solution. Click here to go to the answer

Author Question: A primary health care provider orders opioid antagonist treatment for a client with respiratory ... (Read 128 times)

Coya19@aol.com

  • Hero Member
  • *****
  • Posts: 601
A primary health care provider orders opioid antagonist treatment for a client with respiratory depression. The nurse should be aware of which of the following conditions that can occur during an abrupt reversal of opioid respiratory treatment?
 
  A) Dizziness
  B) Headache
  C) Vomiting
  D) Lightheadedness

Question 2

Which of the following are evaluations the nurse should make when caring for a client receiving naloxone? Select all that apply.
 
  A) Pain relief is resumed.
  B) Adverse reactions are identified and managed.
  C) Therapeutic response is achieved.
  D) Client demonstrates an understanding of the drug regimen.
  E) Client's respiratory rate is normal.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

xiaomengxian

  • Sr. Member
  • ****
  • Posts: 311
Answer to Question 1

Ans: C
Feedback:
The nurse should know that an abrupt reversal of opioid respiratory depression with an opioid antagonist results in vomiting. The nurse must maintain a patent airway and should turn and suction the client as needed in such cases. Headache, dizziness, and lightheadedness are not known to occur during an abrupt reversal of opioid respiratory treatment.

Answer to Question 2

Ans: A, B, C, D, E
Feedback:
Pain relief is resumed, adverse reactions are identified and managed, therapeutic response is achieved, client demonstrates an understanding of the drug regimen, and client's respiratory rate is normal are evaluations of successful therapy with an opioid antagonist.





 

Did you know?

There are more nerve cells in one human brain than there are stars in the Milky Way.

Did you know?

Amphetamine poisoning can cause intravascular coagulation, circulatory collapse, rhabdomyolysis, ischemic colitis, acute psychosis, hyperthermia, respiratory distress syndrome, and pericarditis.

Did you know?

According to the CDC, approximately 31.7% of the U.S. population has high low-density lipoprotein (LDL) or "bad cholesterol" levels.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.

For a complete list of videos, visit our video library